SureTrader Nadex Advertisement SureTrader
Home > Boards > Free Zone > Health and Sciences >

BioPharma Ideas

RSS Feed
      Hide Sticky   Hide Intro
Moderator: gfp927z Assistants:
Search This Board: 
Last Post: 4/5/2017 7:49:43 PM - Followers: 24 - Board type: Free - Posts Today: 0

A board to discuss biotech and biopharma ideas -


MICRO CAP - (0 - 500 mil) -
***********************************
Amyris (AMRS) - Producing diverse industrial compounds via yeast bioreactors (140 mil)
Cellceutix (CTIX) - Cancer, inflam, antibiotics (Polymedix) (168 mil)
Intec Pharma (NTEC) - Oral drug delivery system (68 mil) ------------------- (Israel)
Organovo (ONVO) - 3-D bioprinting to create human tissues (352 mil)
RespireRx (RSPI) - Ampakines, dronabinol, respiratory indications (Cortex) (12 mil)

SMALL CAP - (500 mil - 2 Bil) -
**************************************
Bluebird Bio (BLUE) - Gene therapies (1.6 Bil)

MID CAP - (2 Bil - 10 Bil) -
********************************
Acadia (ACAD) - Neurological, CNS (3.8 Bil)
Intercept Pharmaceuticals (ICPT) - Liver and intestinal diseases (3.5 Bil) ---- (B)
Ionis Pharmaceuticals (IONS) - RNA-targeted drug (3 Bil)
Jazz Pharma (JAZZ) - Diverse (8.5 Bil) ---------------------------------------------- (Ireland)
Kite Pharma (KITE) - Cancer (2.5 Bil)
Ligand (LGND) - Royalty generating pharma assets, Captisol solubility platform (2.6 Bil)
Medicines Co (MDCO) - Cardio, infectious, diseases (2.5 Bil)
Neurocrine Biosciences (NBIX) - Neurological, endocrine (3.8 Bil)
Seattle Genetics (SGEN) - Cancer, autoimmune, armed MABs (5.7 Bil)
United Therapeutics (UTHR) - Cardio, pulmonary (4.9 Bil)

LARGE CAP - (10 - 30 Bil) -
************************************
Biomarin (BMRN) - Metabolic orphan diseases, cancer (21 Bil)
Incyte (INCY) - Hematologic, cancer, inflam, autoimmune (15 Bil)

VERY LARGE CAP - (30 - 100 Bil) -
*********************************************
Abbott Labs (ABT) - Pharmaceuticals, diverse healthcare products (74 Bil)
Alexion (ALXN) - Rare diseases (44 Bil)
Biogen Idec (BIIB) - Neurodegenerative, hemophilia, autoimmune (72 Bil)
Regeneron (REGN) - Diverse clinical indications (60 Bil) 
Shire (SHPG) - Pharmaceuticals (49 Bil) ---------------------------------------------- (UK)

MEGA CAP - (over 100 Bil) -
************************************
AbbVie (ABBV) - Drug development arm from Abbott Labs (109 Bil)
Allergan (AGN) -  Generic, branded, biosimilar, and OTC pharma products (125 Bil)
Amgen (AMGN) - Blood cell stimulators, other (131 Bil)
Bristol-Myers Squibb (BMY) - Pharmaceuticals (105 Bil)
Celgene (CELG) - Cancer, inflam (102 Bil)
Gilead (GILD) - Infectious diseases, HIV, Hepatitis (168 Bil)
Novartis (NVS) - Pharmaceuticals, healthcare products (246 Bil) -------------------- (Switzerland)
Novo Nordisk (NVO) - Pharma, insulin (150 Bil) --------------------------------------------- (Denmark)
Pfizer (PFE) - Pharmaceuticals (216 Bil)
Roche (RHHBY.PK) - Pharmaceuticals, diagnostics (239 Bil) ------------------------- (Switzerland)

GENERICS -
***************
Dr Reddy's Labs (RDY) - Generics, other (7 Bil) ----------------------------------------------- (India)
Lannett (LCI) - Generic drugs (1.2 Bil)
Mylan Labs (MYL) - Generic drugs (11 Bil)
Perrigo (PRGO) - Generic / OTC drugs, consumer healthcare products (11 Bil) ------(Ireland)
Taro Pharmaceuticals (TARO) - OTC and generic drugs, active ingredients (5 Bil) --(Israel)
Teva (TEVA) - Generics, other (40 Bil) ------------------------------------------------------------ (Israel)

VETERINARY -
*******************
Idexx Labs (IDXX) - Veterinary diagnostic products and services (5 Bil)
Neogen (NEOG) - Food safety testing, animal heath (1.2 Bil)
PetMed Express (PETS) - Veterinary drugs and health products (264 mil)
VCA Antech (WOOF) - Veterinary hospitals (2.1 Bil)
Zoetis (ZTS) - Veterinary drugs and vaccines, Pfizer subsidiary (16 Bil)

DIAGNOSTICS -
*******************
BioRad Labs (BIO) - Products for bio research and clinical diagnostics (2.9 Bil)
Genomic Health (GHDX) - Molecular diagnostics, genomic based lab tests (918 mil)
Myriad Genetics (MYGN) - Diagnostic tests (1.2 Bil)

RESEARCH PRODUCTS -
*********************************
Agilent (A) - Bio-analytical and electronic measurement solutions (16 Bil)
Bio-Techne (TECH) - Research + clinical diagnostic products (3 Bil)
Cambrex (CBM) - Active pharmaceutical ingredients and intermediates (380 mil)

RESEARCH PRODUCTS - CELLS -
********************************************
Organovo (ONVO) - 3-D bioprinting to create human tissues (650 mil)

ANTIBIOTICS -
********************
Cellceutix (CTIX) - Cancer, inflam, antibiotics, acquired Polymedix (184 mil)
Pfizer (PFE) - Zyvox
Roche (RHHBY) - Macrocycle antibiotics with Polyphor, arylomycins with RQx (Switzerland)

INDUSTRIAL BIOTECH -
******************************
Novozymes (NVZMY.PK) - Industrial enzymes, microorganisms, and bio ingredients -----(Denmark)

MORE
**********
Advaxis (ADXS) - Cancer (450 mil) ---- (D)
Array (ARRY) - Cancer, inflammatory (811 mil)
InVivo Therapeutics (NVIV) - Biopolymer scaffolding for spinal cord injuries (150 mil)
Momenta (MNTA) - Complex biosimilars, biogenerics (754 mil) ---- (D)
Sarepta (SRPT) - RNA-based therapeutics for rare and infectious diseases(1.2 Bil)
Spectrum (SPPI) - Cancer, other (750 mil)

MISC -
**********
Senomyx (SNMX) - Taste modulators, flavor enhancing technology
Sensient (SXT) - Flavors, colors, fragrances (2 Bil)

OTHER -
************
Anavex (AVXL) - Neurological, CNS (210 mil)
Eagle Pharmaceuticals (EGRX) - Cancer (673 mil) ---- (D)
Enanta (ENTA) - Infectious diseases, Hep C (450 mil) ---- (D)

ACQUIRED -
****************
Abgenix (ABGX) - Monoclonal antibodies (Amgen)
Actavis (ACT) - Generics, other (merged with Allergan
Ariad (ARIA) - Cancer (Takeda) 
Bio-Reference Labs (BRLI) - Clinical laboratory testing services (Opko)
Celator (CPXX) - Cancer, dosage optimized liposome encapsulated combo drugs (Jazz)
Cephalon (CEPH) - CNS (Teva) ------------------------------------------------------------------(Israel)
Cubist (CBST) - Antibiotics (Merck)
Cynapsus (CYNA) - Oral rescue med for Parkinson's disease (Canada) (Sunovion)
Durata Therapeutics (DRTX) - Antibiotics (Actavis)
Gentium (GENT) - Veno-occlusive disease (Italy) (Jazz)
Genzyme (GENZ) - Orphan diseases, other (Sanofi) --------------------------------------(France)
Given Imaging (GIVN) - Pill-Cam capsules for visualization of GI tract (Israel) (Covidien)
Idenix (IDIX) - Infectious diseases, Hep C (Merck)
Inhibitex (INHX) - Infectious diseases (BMY)
Life Technologies (LIFE) - Molecular biology related products (TMO)
Medarex (MEDX) - Monoclonal antibodies (BMY)
Medivation (MDVN) - Cancer, neurological (10.3 Bil) (Pfizer)
Memory Pharma (MEMY) - CNS (Roche) ---------------------------------------------(Switzerland)
MGI Pharma (MOGN) - Oncology related (Eisai) -------------------------------------------(Japan)
Micromet (MITI) - Cancer (Amgen)
Millenium Pharma (MLNM) - Cancer (Takeda) ---------------------------------------------(Japan)
MWI Veterinary Supply (MWIV) - Veterinary drugs and products (Amerisource Bergen)
Onyx (ONXX) - Cancer (Amgen)
Optimer - Antibiotics (Cubist) 
Pharmacyclics (PCYC) - Cancer, immune diseases (Abbvie)
Pharmasset (VRUS) - Infectious diseases (Gilead)
Polymedix (PYMX) - Defensin-mimetic antibiotics, other (Cellceutix)
Prolor (PBTH) - Long acting versions of therapeutic proteins (Opko)
Salix (SLXP) - GI related disorders (Valeant)
Santarus (SNTS) - GI, diabetes, other (Salix)
Sigma Aldrich (SIAL) - Bio research reagents, chemicals (Merck)
Synageva (GEVA) - Lysosomal storage disorders (Alexion)
Trius (TSRX) - Antibiotics (Cubist)
ViroPhama (VPHM) - Angioedema, infectious diseases, other (Shire) ------------------(UK)



 
PostSubject
#966   Parabel (PABL) is growing commercially what is considered WildlifeTracker 04/05/17 07:49:43 PM
#965   Some believe TEVA will have interest in OWCP FELLER 04/05/17 12:05:47 PM
#964   >>> Cellceutix Releases Favorable Topline Findings as Part gfp927z 03/25/17 04:32:55 PM
#963   Cannabis has to move from being tested on DinoADZ 03/10/17 05:56:51 AM
#962   Teva - >>> Why Battered Biotech Teva Is gfp927z 03/09/17 06:30:22 PM
#961   >>> Teva Said to Weigh Options for Branded gfp927z 02/14/17 12:42:43 PM
#960   >>> Teva Pharmaceutical Industries Ltd. Reports Q4 Improvement gfp927z 02/14/17 12:17:05 PM
#959   >>> We’re in the year of the biotech gfp927z 02/08/17 11:42:39 AM
#958   >>> Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, gfp927z 01/24/17 10:31:46 AM
#957   European company Advanced Oncotherapy wants to DinoADZ 01/24/17 08:30:34 AM
#956   European company Advanced Oncotherapy wants to DinoADZ 01/24/17 08:30:28 AM
#955   >>> Opinion: We’re in the year of the gfp927z 01/23/17 10:22:45 AM
#954   JonhsonJohnson's buys another private company, price undisclosed DinoADZ 01/20/17 09:02:46 AM
#953   Teva - Dew's comments - gfp927z 01/18/17 05:06:55 PM
#952   Ariad - >>> Takeda Pharmaceutical to buy Ariad gfp927z 01/09/17 11:08:16 AM
#950   Thanks, MYMX does look interesting from a science gfp927z 01/08/17 11:15:00 AM
#949   >>> Mymetics Corporation, a vaccine company, focuses on gfp927z 01/08/17 10:40:36 AM
#948   >>> Mymetics Starts Research Project with Sanofi for gfp927z 01/08/17 10:36:14 AM
#947   Sanofi might be looking to buy a very Harry Wickey 01/07/17 07:48:25 PM
#946   >>> Could Sanofi Acquire BioMarin In Wake Of gfp927z 01/07/17 12:19:03 PM
#945   >>> These 5 Biotech Stocks Could Be Big gfp927z 01/07/17 12:07:20 PM
#944   >>> FDA rejects Cempra's antibiotic for pneumonia, shares sink gfp927z 01/06/17 09:32:17 AM
#943   OWCP really should be on your radar, folks. FELLER 01/05/17 08:45:34 AM
#942   >>> RespireRx Pharmaceuticals Inc. Announces Positive Results from gfp927z 12/23/16 12:08:59 PM
#941   >>> RespireRx Pharmaceuticals Inc. Announces Data for CX1739 gfp927z 12/23/16 12:00:26 PM
#940   https://www.campisilaw.ca/blog/know-medical-malpractice-case/ htt klinton 12/15/16 01:19:11 AM
#939   >>> Cellceutix Provides Corporate Update and Reports Q1 gfp927z 11/17/16 07:19:58 PM
#938   Cempra -- >>> FDA Advisory Committee Votes That gfp927z 11/05/16 10:38:07 AM
#937   >>> Cempra shares plummet ahead of FDA meeting gfp927z 11/04/16 10:55:03 AM
#936   NMUS - Presentation at the 18th Annual Rodman MasterBlastr 10/31/16 11:15:23 PM
#935   Blade, >> CEMP << gfp927z 10/29/16 10:31:40 AM
#934   re: CEMP bladerunner1717 10/28/16 08:22:39 PM
#933   >>> Cempra Drops on Manufacturing Issues gfp927z 10/28/16 08:00:24 PM
#932   >>> Cempra Presents Analysis Showing Rates of Failure gfp927z 10/07/16 08:18:02 AM
#931   >>> Amyris, Inc. provides various alternatives to a gfp927z 10/06/16 09:02:57 PM
#930   >>> Amyris - A Juggernaut In The Making gfp927z 10/06/16 08:35:54 PM
#929   re: XXII bladerunner1717 10/05/16 07:38:19 PM
#928   >>> Cempra tumbles on safety concerns of anti-bacterial drug gfp927z 10/03/16 06:58:18 PM
#927   >>> Cempra (CEMP) Stock Soars on Solithromycin Results gfp927z 10/03/16 06:53:10 PM
#926   Cempra - >>> New Antibiotic Shows Promise as gfp927z 10/03/16 06:46:30 PM
#925   >>> Cempra's Lead Antibiotic Has Blockbuster Potential gfp927z 10/03/16 06:40:48 PM
#924   >>> Amyris Expands in Global Nutraceuticals Market with gfp927z 09/30/16 09:03:01 PM
#923   Pradaxa reversal agent - >>> FDA approves Praxbind, gfp927z 09/30/16 05:43:59 PM
#922   >>> Cempra Announces Anti-NASH Effects of Solithromycin: Interim gfp927z 09/30/16 11:12:44 AM
#921   Biomarin - >>> Is BioMarin's Promising Pipeline Enough gfp927z 09/27/16 10:03:43 PM
#920   >>> Cempra to Present Solithromycin at FDA Antimicrobial gfp927z 09/27/16 05:20:54 PM
#919   Cempra - >>> 3 Bold Bets on the gfp927z 09/27/16 05:18:07 PM
#918   >>> Amyris: The New Colossus aims to unlock gfp927z 09/22/16 12:38:17 PM
#917   The Amyris chart looks interesting. Key resistance gfp927z 09/17/16 11:07:41 AM
#916   Blade, Thanks, I'll check those out. gfp927z 09/15/16 09:21:29 PM
PostSubject